Trophoblast Stem-Cell-Derived Exosomes Improve Doxorubicin-Induced Dilated Cardiomyopathy by Modulating the let-7i/YAP Pathway
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 22, 948-956
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81870291)
This publication has 42 references indexed in Scilit:
- Let-7 in Cardiovascular Diseases, Heart Development and Cardiovascular Differentiation from Stem CellsInternational Journal of Molecular Sciences, 2013
- Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injuryBiochemical and Biophysical Research Communications, 2013
- Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolutionNature Reviews Immunology, 2013
- Fetal Cells Traffic to Injured Maternal Myocardium and Undergo Cardiac DifferentiationCirculation Research, 2012
- Pervasive roles of microRNAs in cardiovascular biologyNature, 2011
- mir-200c Regulates Induction of Apoptosis through CD95 by Targeting FAP-1Molecular Cell, 2010
- Doxorubicin CardiomyopathyCardiology, 2009
- Phenopedia and Genopedia: disease-centered and gene-centered views of the evolving knowledge of human genetic associationsBioinformatics, 2009
- Placenta-derived stem cells: new hope for cell therapy?Cytotechnology, 2008
- MicroRNAsCell, 2004